Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Howard G. Welgus Insider Profile
4 Followers
Howard G. Welgus, Director at Arcutis Biotherapeutics, holds 161.94K shares in Arcutis Biotherapeutics (Ticker: ARQT).
Howard G. Welgus Arcutis Biotherapeutics (ARQT)Director
Arcutis Biotherapeutics (ARQT)
Director
Ranked #89,075 out of 100,230 Corporate Insiders
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-70.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Howard G. Welgus's holdings
Insider Roles
Director
Roles that Howard G. Welgus holds in companies
Most Profitable Insider Trade
The most profitable trade made by Howard G. Welgus
Howard G. Welgus's Trading History
List of latest transactions for each holding click on a transaction to see Howard G. Welgus's performance on stock
You May Also Like
Howard G. Welgus insider profile FAQ
What is the percentage of profitable transactions made by Howard G. Welgus?
The percentage of profitable transactions made by Howard G. Welgus is 0%.
What is the average return per transaction made by Howard G. Welgus?
The average return per transaction made by Howard G. Welgus is -70.90%.
What stocks does Howard G. Welgus hold?
Howard G. Welgus holds: ARQT stocks.
What was Howard G. Welgus’s latest transaction?
Howard G. Welgus latest transaction was an Uninformative Sell of $125.10K.
What was Howard G. Welgus's most profitable transaction?
Howard G. Welgus’s most profitable transaction was an Informative Sell of ARQT stock on July 2, 2024. The return on the trade was -53.70%.
What is Howard G. Welgus's role in Arcutis Biotherapeutics?
Howard G. Welgus's role in Arcutis Biotherapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.